News Focus
News Focus
Replies to #55844 on Biotech Values
icon url

DewDiligence

12/07/07 2:50 PM

#55846 RE: masterlongevity #55844

>OPK – the earlier [Bevasiranib] efficacy data was not competitive with Lucentis, Avastin or even early VEGF-Trap data<

Not even close, IMO. If Bevasiranib were owned by a Big Pharma, I think the program would already have been killed.